NEW YORK (GenomeWeb News) – The National Science Foundation is preparing the details of how it will parse out much of the $3 billion it received from the American Recovery and Reinvestment Act, which will include funding for standard grants, cutting-edge research, some previously declined proposals, and research infrastructure.

In a recent speech to employees about how the NSF will separate and spend the stimulus funds, Director Arden Bement said that the foundation will use those and other programs to distribute the $2 billion that is available for research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.